ClinicalTrials.gg
Drug

Tipiracil clinical trials

Its developmentBy Simcere Pharmaceutical Group, step by step1 company-led study, furthest phase 3: when each phase was reached, its deals, target and what is ahead.
studies test it
6
open now
4
in phase 3
2
first study started
2016

Counted the way a researcher would: Tipiracil with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses tipiracil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tipiracil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
25 Apr 2016 · Lonsurf · EMEA/H/C/003897 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

Studies by the year they started

6 studies that test it; most in 2025 (5)

Studies that test tipiracil, by start year
YearStudies
20161
20255

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 1 · Other 5

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · Institut de Recherches Internationales Servier (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Sun Yat-sen University (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Often tested with

Tested in the same studies.

Trifluridine (6) · HMPL-013 (2) · Bemarituzumab (1) · Paclitaxel (1) · Ramucirumab (1) · Irinotecan (1) · Bevacizumab (1) · Suvemcitug (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test tipiracil.

Studies

Open first, then newest update. How each study uses tipiracil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Given beside what is tested · 4 — tipiracil is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with tipiracil

Codes

What other systems call tipiracil · ClinicalTrials.gg INT000590

  • MeSH (NLM) C000613754tipiracilOne source NLM
  • UNII (FDA) NGO10K751PTIPIRACILConfirmed FDA, NLM, Wikidata
  • RxNorm 1670304Confirmed FDA, Wikidata
  • Wikidata Q21098889tipiracilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152646TipiracilOne source FDA
  • DrugBank DB09343One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.